Malignant Mesothelioma Therapeutic Pipeline Review, H1 2015

1
Malignant Mesothelioma Therapeutic Pipeline
Review, H1 2015 By RnRMarketResearch

• Browse more reports Cancer therapeutics at
• http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals/therapeutics/cancer-therapeut
  ics

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
2
Malignant Mesothelioma Therapeutic Pipeline
Review, H1 2015

• This report provides comprehensive information on
  the therapeutic development for Malignant
  Mesothelioma, complete with comparative analysis
  at various stages, therapeutics assessment by
  drug target, mechanism of action (MoA), route of
  administration (RoA) and molecule type, along
  with latest updates, and featured news and press
  releases. It also reviews key players involved in
  the therapeutic development for Malignant
  Mesothelioma and special features on late-stage
  and discontinued projects.
• The report enhances decision making capabilities
  and help to create effective counter strategies
  to gain competitive advantage. It strengthens RD
  pipelines by identifying new targets and MOAs to
  produce first-in-class and best-in-class products.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
3
Malignant Mesothelioma Therapeutic Pipeline
Review, H1 2015
The report is built using data and information
sourced from Global Markets Direct's proprietary
databases, Company/University websites, SEC
filings, investor presentations and featured
press releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Direct's team. Drug
profiles/records featured in the report undergoes
periodic updation following a stringent set of
processes that ensures that all the profiles are
updated with the latest set of information. Additi
onally, processes including live news deals
tracking, browser based alert-box and clinical
trials registries tracking ensure that the most
recent developments are captured on a real time
basis.
(This is a premium report price at US2000 for a
single user PDF license)
http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
4
Malignant Mesothelioma Therapeutic Pipeline
Review, H1 2015

• Scope
• Coverage of the Malignant Mesothelioma pipeline
  on the basis of target, MoA, route of
  administration and molecule type
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• A review of the Malignant Mesothelioma products
  under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources
• The report reviews key players involved in the
  therapeutics development for Malignant
  Mesothelioma and enlists all their major and
  minor projects

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
5
Malignant Mesothelioma Therapeutic Pipeline
Review, H1 2015

• Reasons to buy
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and scope
• Devise corrective measures for pipeline projects
  by understanding Malignant Mesothelioma pipeline
  depth and focus of Indication therapeutics
• Identify and understand important and diverse
  types of therapeutics under development for
  Malignant Mesothelioma
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage

(This is a premium report price at US2000 for a
single user PDF license)
http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
6
Malignant Mesothelioma Therapeutic Pipeline
Review, H1 2015
Table of Contents Table of Contents 2List of
Tables 5List of Figures 7Introduction 8Global
Markets Direct Report Coverage 8Malignant
Mesothelioma Overview 9Therapeutics Development
10Pipeline Products for Malignant Mesothelioma -
Overview 10Pipeline Products for Malignant
Mesothelioma - Comparative Analysis 11Malignant
Mesothelioma - Therapeutics under Development by
Companies 12Malignant Mesothelioma -
Therapeutics under Investigation by
Universities/Institutes 17
http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
7
Malignant Mesothelioma Therapeutic Pipeline
Review, H1 2015

• For more details contact Mr. Ritesh Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

(This is a premium report price at US2000 for a
single user PDF license)
RnRMarkertResearch RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR Market Research library has
syndicated reports by leading market research 
publishers across the globe.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441